Results 131 to 140 of about 36,016 (212)

Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous-venous extracorporeal membrane oxygenation (VV-ECMO): A case report. [PDF]

Br J Clin Pharmacol
Zwart TC, Leegwater E, Ottens TH, Schippers EF, Wilms EB, Burger DM, van Nieuwkoop C, Bosma LBE.   +7 more
europepmc   +1 more source

Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens. [PDF]

AIDS
Marcelin AG, Soulie C, Wirden M, Gruber J, Prata Menezes N, Lim T, Barriere G, Descamps D, Charpentier C, Calvez V.   +9 more
europepmc   +1 more source

Antiretroviral therapy switch among Medicare beneficiaries with HIV. [PDF]

J Manag Care Spec Pharm
Christoph MJ, Mordi U, Li S, Guo H, Gong T, Lim T, Park S, Zachry W, Tien PC.   +8 more
europepmc   +1 more source

HIV-1 Genetic Diversity and Drug Resistance Mutations Among Patients on Antiretroviral Therapy in Nairobi County, Kenya. [PDF]

Adv Virol
Angiro E, Ngayo M, Wahome C, Mungiria J, Nyamache A.   +4 more
europepmc   +1 more source

Regional Variations of Rates and Determinants of Drug Resistance Mutations in People Failing First-line Therapy for HIV-1: A Substudy from the D2EFT Phase 3b/4 Clinical Trial. [PDF]

Clin Infect Dis
Obeng BM, Hutchinson J, Shaik A, Chetchotisakd P, Azwa I, Wulan WN, Kumarasamy N, Wolff M, Bruguera J, Losso M, Kaplan R, Diallo MS, Eriobu N, Musoro G, Kumalawati J, Badamasi A, Fitriah M, Mulya DP, Law M, Matthews G, Di Giallonardo F, Kelleher AD, Dolutegravir and Darunavir Evaluation in Adults Failing Therapy (D2EFT) Study Group .   +22 more
europepmc   +1 more source

Viral load suppression among pregnant and breastfeeding women living with HIV in Ghana: a prospective longitudinal study. [PDF]

BMC Infect Dis
Dame JA, Nightingale KJ, Sefogah P, Aggrey I, Ahmed D, Afrane AKA, Lowenthal ED.   +6 more
europepmc   +1 more source

Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity. [PDF]

Infect Dis Ther
Wang Z, Liu L, Chen J, Wang J, Shen Y, Qi T, Tang Y, Song W, Sun J, Xu S, Yang J, Chen Y, Shao Y, Zhang R.   +13 more
europepmc   +1 more source

Determinants and outcomes of adverse drug reactions among people living with HIV on antiretroviral therapy in Nigeria. [PDF]

BMC Infect Dis
Etuk VP, Adeoye IA, Salawu MM, Fawole OI.   +3 more
europepmc   +1 more source

Evolution and forecasting of antiretroviral therapy utilisation in British Columbia: a population-level analysis of provincial drug treatment programme data, 2014-2024. [PDF]

BMJ Open
Lima VD, Mokhtari Jazi A, Montaner JSG.
europepmc   +1 more source

Metabolic syndrome and its risk factors among adults living with HIV receiving antiretroviral therapy in Zambia: an ambidirectional cohort study. [PDF]

Sci Rep
Hamooya BM, Bosomprah S, Masenga SK, Mutengo KH, Cheelo C, Siame L, Simushi P, Mwakyoma T, Mudenda J, Mutale W, Halwiindi H, Bedimo R, Shrestha S, Chanda C, Heimburger DC, Lipworth L.   +15 more
europepmc   +1 more source